OCT New England

Biotech companies rely on CROs and other service providers to take care of the operational aspects of clinical trials and ultimately achieve market approval, so finding a trustworthy and efficient outsourcing partner is one of the most vital aspects of running a successful clinical trial.

The fourth annual Outsourcing in Clinical Trials New England conference will explore the latest and most important topics in the field of clinical outsourcing.

Industry experts speaking at OCT New England

The fourth annual OCT New England will bring together respected industry experts such as:

• Robert D. Arbeit, MD – vice president, clinical development, Idera Pharmaceutics
• Lori Barrentine – director clinical affairs, Pamlab
• Christina Bodurow – senior director, external sourcing and business management, Eli Lilly
• Mike Collins – VP global clinical operations, Alexion Pharmaceuticals
• Meredith Frank-Molnia – clinical affairs manager, Anika Therapeutics
• Brooke Mastrorio – director, clinical affairs, DePuy Spine
• Daniel McCarthy – associate director clinical affairs, Radius Health
• Lynn McGovern – director, clinical outsourcing, Millennium: The Takeda Oncology Company
• Lynn Newbould – senior director, outsourcing and clinical contracts, Molecular Insight Pharmaceuticals
• Hemant Patel – director clinical programs, Shire HGT
• Joe Popowicz – director, clinical operations, Stryker
• David Sherris – president and CEO, Paloma Pharmaceuticals
• Susan Stewart, FRAPS, RAC – senior vice president regulatory, quality and compliance, Tokai Pharmaceuticals
• Kathryn Stiede – director clinical operations, Avila Pharmaceuticals
• Jennifer Sugarman – associate director clinical affairs, pSivida
• Lisa Virzi – project manager, ARIAD Pharmaceuticals

Enhance your clinical trial outsourcing methodology

Whether you are a start-up or an established company looking to enhance your existing outsourcing methodology, OCT New England can help you ensure the smooth completion of clinical trial procedures.